U.S. Entertainment Stock News

Global Partners LP recently declared a cash distribution of US$0.7600 per unit (US$3.04 on an annualized basis) for the October–December 2025 period, payable on February 13, 2026 to unitholders of record as of February 9, 2026, and scheduled its fourth-quarter and full-year 2025 results release for February 27, 2026. This distribution decision, coming just ahead of the upcoming earnings release, highlights management’s current capital return priorities and income profile for...

Covista, formerly Adtalem Global Education, has announced a corporate rebrand. The company has partnered with Google Cloud to launch AI credential programs for healthcare professionals. The rebrand and partnership highlight a sharpened focus on technology enabled healthcare education. These developments are material for Covista's positioning as a healthcare workforce education provider on the NYSE:ATGE. For you as an investor, the Covista rebrand and its work with Google Cloud point to a...

Tidewater recently issued 2026 revenue guidance of US$1.32 billion to US$1.37 billion, reaffirmed vessel utilization near 76%, and left about US$500 million remaining under its share repurchase authorization, while Sagil Capital fully exited its position in the stock. At the same time, Black Bear Value Fund reiterated Tidewater as a key holding, highlighting the company’s sizeable offshore support vessel fleet, reduced debt, and capital return plans as reasons for its continued interest...

IQVIA Holdings (NYSE:IQV) has entered a collaboration with the Duke Clinical Research Institute to advance clinical research in obesity and cardiometabolic trials. The partnership focuses on complex clinical programs and aims to broaden access to diverse patient groups in areas of rising healthcare focus. For investors watching IQVIA Holdings at a share price of $168.85, this new collaboration sits against a backdrop of weak recent returns. The stock has declined 6.7% over the past week,...

MoonStone Phase 2 data and why it matters for Zenas BioPharma (ZBIO) Zenas BioPharma (ZBIO) is in the spotlight after presenting Phase 2 MoonStone trial results for obexelimab in relapsing multiple sclerosis. The drug met its primary endpoint with a highly statistically significant reduction in new active brain lesions. For investors watching ZBIO, the detailed 24 week dataset, together with the late breaking presentation at the ACTRIMS Forum 2026, raises fresh questions about how this...

Safehold (NYSE:SAFE) received an S&P credit rating upgrade to A- with a stable outlook. The company announced a share buyback program alongside plans to monetize more of its unrealized capital appreciation, known as "Carats." Management outlined an expansion of ground lease originations, including a focus on affordable housing and broader geographic reach. Safehold, trading at $14.84, is working to reposition itself in the eyes of both credit markets and equity investors. The stock is up...

What the Hiab partnership could mean for Custom Truck One Source The new dealer agreement between Hiab and Custom Truck One Source (CTOS) expands sales and service coverage for HIAB cranes and MOFFETT forklifts across Western and Northeastern states, providing investors with an additional data point on the company’s growth ambitions. See our latest analysis for Custom Truck One Source. Recent news around the Hiab agreement sits alongside strong share price momentum, with a 22.3% 90 day share...

Applied Materials (NasdaqGS:AMAT) agreed to a US$252.5 million settlement with the U.S. Department of Commerce related to export violations tied to shipments to China. U.S. Department of Justice and SEC reviews have been closed without further action, ending a period of regulatory scrutiny for the company. This resolution closes a major compliance overhang and clarifies Applied Materials' legal exposure around past export control issues. Applied Materials, a key supplier of equipment and...

Wayfair stock performance sets the stage Wayfair (W) has drawn fresh investor attention after a mixed stretch in the share price, with a 6% decline over the past week and a larger pullback over the past month. See our latest analysis for Wayfair. That recent 30 day share price return of 30.68% and 22.56% year to date share price decline contrast with a 1 year total shareholder return of 73.40% and a 3 year total shareholder return of 61.65%, suggesting momentum has cooled after a strong...

Quantum Computing Inc. (NasdaqCM:QUBT) has agreed to acquire Luminar Semiconductor to expand its photonic technology capabilities. The transaction is intended to strengthen QUBT's patent portfolio and deepen its engineering bench in quantum photonics. Management expects the deal to support government and defense contracts and help move toward more scalable manufacturing. Quantum Computing Inc. focuses on quantum and photonic computing solutions that aim to tackle complex optimization and...

Clorox has completed a $2.25b acquisition of GOJO Industries, the maker of Purell. The company has also finished a major ERP system implementation while managing operational and margin pressures. Clorox continues its long-running dividend payments as it absorbs GOJO and focuses on cost and margin recovery. For investors watching NYSE:CLX, these moves come with the stock trading around $124.64 and mixed multi year performance, including a 23.6% return year to date and a 22.6% decline over...

Wondering if Ross Stores at around US$194.85 is still a good entry, or if most of the value is already reflected in the price? This article is built to help you think that through clearly. The stock shows a 3.0% return over the last 7 days, 0.8% over 30 days, 6.6% year to date, 40.3% over 1 year and 74.6% over 3 years, which may influence how you view its current risk and return trade off. Recent coverage of Ross Stores has centered on its position in off price retail and how its store...

CarMax (NYSE:KMX) has appointed Keith Barr as its next President and Chief Executive Officer. Barr previously served as CEO of InterContinental Hotels Group, bringing more than 25 years of global consumer and hospitality experience. CarMax, a major used car retailer in the United States, operates in a sector that has been reshaped by changing consumer preferences, digital car shopping, and evolving supply conditions for used vehicles. Investors often watch leadership changes at companies...

US regulators are examining whether Apple News shows political bias in how it curates and presents content. Apple is also reported to be facing delays to a major AI driven Siri upgrade that had been widely anticipated by users and investors. These developments arrive as Apple, NasdaqGS:AAPL, continues to lean on services and AI related features as important parts of its long term product mix. For anyone watching NasdaqGS:AAPL, this combination of regulatory questions and product timing...

Nike (NYSE:NKE) is implementing major layoffs at its Converse unit as part of a broad restructuring effort. The shake up includes senior leadership changes and a company wide directive for Converse staff to work from home. The moves follow repeated periods of underperformance at Converse and the rollout of a "Win Now" turnaround plan. Investors are watching for clarity on whether Nike might consider divestiture or deeper changes to the Converse brand. Nike, through Converse, is exposed to...

TMC The Metals Company (NasdaqGS:TMC) is progressing its undersea mining plans for polymetallic nodules while facing unresolved regulatory questions. The company is preparing its first potential commercial project in international waters, which still requires approval from the International Seabed Authority before production can start. Recent updates highlight both the prospect of accessing critical metals from the seafloor and the operational and technological hurdles that remain. TMC The...

QuidelOrtho (QDEL) closed out FY 2025 with Q4 revenue of US$723.6 million and a basic EPS loss of US$1.92, while the trailing twelve months showed revenue of US$2.73 billion and a basic EPS loss of US$16.69. Over recent quarters, the company has seen revenue move from US$707.8 million in Q4 2024 to US$613.9 million in Q2 2025, then to US$699.9 million in Q3 2025 and US$723.6 million in Q4 2025. This was alongside quarterly EPS losses that ranged from US$0.19 to US$10.78. With trailing twelve...

Open Text (NasdaqGS:OTEX) is back in focus after its latest earnings release, where revenue topped analyst expectations despite a small year-on-year decline, and the company lifted its fiscal 2026 share repurchase authorization by US$200 million. See our latest analysis for Open Text. The earnings beat and larger buyback plan sit against a weaker recent share price, with a 30 day share price return of 25.84% decline and a 1 year total shareholder return of 13.42% decline, suggesting momentum...

If you are wondering whether Amer Sports at around US$38.52 is offering good value or asking too much, you are not alone. This article is here to unpack that question in plain terms. The stock has seen a 7.8% return over the last 7 days, 0.7% over 30 days, 2.7% year to date and 24.7% over the past year. This may have some investors reassessing both its growth potential and risk profile. Recent coverage around Amer Sports has focused on its position in the sports and outdoor equipment space,...

N-able (NYSE:NABL) announced its Empower 2026 conference, centered on business resilience in cybersecurity. The event will spotlight emerging technology trends, expanded technical tracks, and interactive workshops. Empower 2026 is positioned as a forum for business leaders and IT professionals to address evolving cyber risks. N-able, known for its software solutions that support managed service providers and IT teams, is using Empower 2026 to put cybersecurity resilience front and center...

Sana Biotechnology recently faced an analyst downgrade amid growing concerns about a tighter U.S. FDA regulatory framework for gene therapies, putting a spotlight on its cash usage and clinical progress ahead of its mid-March 2026 quarterly update. This combination of shifting regulation and divergent analyst opinions has intensified questions about how the company will balance scientific ambition with financial resilience. We’ll now examine how the analyst downgrade against a more stringent...

Avadel Pharmaceuticals (AVDL) has drawn investor attention after recent trading left the shares around $21.64, prompting fresh interest in how its narcolepsy focused portfolio and current fundamentals line up for long term holders. See our latest analysis for Avadel Pharmaceuticals. While the recent 1 day share price return of around 0.05% at US$21.64 and a 30 day share price return of 0.65% suggest only modest short term movement, the 1 year total shareholder return of 151.34% points to...

Five9 recently expanded its partnership with Google Cloud, launching a joint Enterprise CX AI solution that integrates Five9’s Intelligent CX Platform with Google’s Gemini Enterprise and Vertex AI to enhance AI-driven customer experiences and operational agility across contact center workflows. This move deepens Five9’s ecosystem reach by pairing its contact center technology with Google’s AI capabilities, potentially strengthening its role in end-to-end, AI-augmented customer experience...

If you are wondering whether Hormel Foods shares are starting to look attractively priced or still have room to fall, the numbers behind the stock can offer some useful clues. The share price closed at US$23.44, with returns of a 6.6% decline over the last 7 days, a 0.3% decline over 30 days, roughly flat at 0.2% year to date, and declines of 14.2% over 1 year, 41.7% over 3 years, and 42.4% over 5 years. Recent headlines around Hormel Foods have focused on its position as a long established...